Skip to main content
Clinical Trials/PACTR201812901591120
PACTR201812901591120
Completed
Phase 4

The comparison of efficiency of misoprostol used in different ways in postpartum hemorrhage.

Not provided0 sites400 target enrollmentNovember 29, 2018

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
Not provided
Enrollment
400
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 29, 2018
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Not provided

Eligibility Criteria

Inclusion Criteria

  • 1\. Pregnant women between the ages of 18\-40
  • 2\. Having pregnancy between 37\-42 weeks
  • 3\. Women on vaginal delivery
  • 4\. Pregnant women with BMI \<35
  • 5\. Nulliparity

Exclusion Criteria

  • 1\. Women with multiple pregnancy
  • 2\. Pregnant women with myoma
  • 3\. Pregnant women with polyhydramnios
  • 4\. Pregnant women with chorioamnionitis
  • 5\. Pregnant women with placental abnormalities
  • 6\. Pregnant women with bleeding diathesis
  • 7\. Pregnant women with caesarean
  • 8\. Pregnant women with low platelet
  • 9\. Women who do not want to participate
  • 10\. Pregnant women with allergic reactions to drug

Outcomes

Primary Outcomes

Not specified

Similar Trials